2 ASX shares I'd buy with $1,000

Jewellery retailer Lovisa is one of the ASX shares I would invest in.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • There are two particular ASX shares I would like to buy with $1,000
  • Lovisa is a global affordable jewellery retailer
  • The MOAT ETF is a portfolio full of businesses with competitive advantages

I think the current ASX share market could prove to be a long-term buying opportunity. Volatility is elevated and lots of ASX shares have seen their share prices fall.

Looking at compelling businesses right now could make a lot of sense because of the uncertainty that exists in the market. Lower prices could be better value for investors.

With that in mind, I think these two ASX shares could be compelling ideas if I were investing $1,000:

A man in suit and tie is smug about his suitcase bursting with cash.

Image source: Getty Images

Lovisa Holdings Ltd (ASX: LOV)

Lovisa is one of the more exciting opportunities in the ASX retail sector, in my opinion. It has a global store network that sells affordable jewellery, focused on younger shoppers.

The company earns a good amount of profit from each new store it opens. Lovisa is steadily opening more locations in the countries it's operating in, and it's also considering opening in new markets.

Lovisa's number of stores in Australia grew from 153 in FY21 to 158 in HY22. The number of US stores increased from 63 to 81. Middle East stores went up from 36 to 44. The ASX share is also working on its digital offering, which it thinks is in its "infancy stage".

In HY22, revenue grew by 48.3% to $217.8 million. Net profit after tax (NPAT) jumped 70.3%, demonstrating the operating leverage of the business.

The ASX share continues to see more growth, which can help drive profit higher. Trading in the first eight weeks of the second half of FY22 saw comparable store growth of 12.1%, with total sales up 61.7%.

I think the business can keep growing its store network, particularly in untapped markets. It's also paying a nice dividend. In HY22 it grew its dividend to 37 cents per share, up from 20 cents per share. Lovisa offers a trailing partially franked dividend yield of 3.5%.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

This is an exchange-traded fund (ETF) that is designed to own a portfolio of high-quality businesses that are valued at attractive prices.

What's the ASX share about? The idea of a 'wide moat' is referring to a business' competitive advantages. The stronger the competitive advantage, the wider the economic moat is. The moat analogy is about how difficult it is for a competitor to 'invade'.

For Morningstar analysts, which are the people that decide the businesses that go into the MOAT ETF, they are looking for businesses where the economic moat is very likely to persist for at least the next decade and has a good chance of lasting at least two decades.

Once Morningstar has identified those businesses with strong, long-term economic moats, shares are only bought for the MOAT ETF if they are trading at attractive prices relative to Morningstar's estimate of fair value.

At the latest disclosure from 13 May 2022, these are the investments that have a weighting of at least 2.5% in the ASX share's portfolio: Campbell Soup, Merck & Co, Kellogg, Philip Morris, Constellation Brands, Polaris, Medtronic, Western Union, Gilead Sciences and Zimmer Biomet.

The VanEck Morningstar Wide Moat ETF has an annual management fee of around 0.49%, which I think is reasonable for what it does.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Gilead Sciences. The Motley Fool Australia has recommended Lovisa Holdings Ltd and VanEck Vectors Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

What went wrong this Wednesday?

Read more »

Broker analysing the share price.
Opinions

Down 63%, I think WiseTech shares could be heading for a huge comeback

WiseTech shares could be gearing up for a major rebound.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Broker Notes

Brokers rate these 5 ASX shares as a strong buy, and tip upsides of 28% to 62%

Do you own any of these ASX shares in your portfolio?

Read more »

Disappointed man with his hand to his forehead, looking at a falling share price on his laptop.
ASX Share Market News

The ASX 200 is down nearly 4% in a month. Is the sell-off getting serious?

The market has slipped again after a rough few weeks.

Read more »

Man ponders a receipt as he looks at his laptop.
Opinions

Down 13% in a week: Is the Xero share price finally cheap enough to buy?

Investors are paying far less for a business still growing strongly.

Read more »

US navy ship sailing along at sunset.
Mergers & Acquisitions

Austal shares surge 6% as another bidder enters the race

Austal shares are climbing after a new offer emerged.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

Expert names 2 beaten-down ASX All Ords healthcare shares to buy today

A leading analyst expects these two beaten-down ASX healthcare stocks are primed for a rebound.

Read more »

Red percentage sign in front of a chart.
Broker Notes

Macquarie makes a big call on a September interest rate hike

The RBA has been sending strong signals, the broker says.

Read more »